ImmunoBiochem is an immuno-oncology biopharmaceutical company that has developed a disruptive approach to targeting unique proteins amplified in cancer secretomes. This differentiated approach enables the selective and efficacious delivery of immunomodulatory and chemotherapeutic payloads into tumour cells, immune cells and tumour-supporting stroma within the tumour microenvironment. ImmunoBiochem has developed several biological therapeutics lead molecules for the treatment of various intractable solid tumours.

Event details

Date: January 9 - 11, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


13 in total